๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Therapeutic targets in the management of Type 1 diabetes

โœ Scribed by P. D. Home

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
84 KB
Volume
18
Category
Article
ISSN
1520-7552

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Can NK cells be a therapeutic target in
Can NK cells be a therapeutic target in human type 1 diabetes?
โœ Francesco Dotta; Cecilia Fondelli; Alberto Falorni ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 73 KB

## Abstract Type 1 diabetes is caused by the autoimmune destruction of insulinโ€producing cells with consequent hyperglycemia and serious chronic complications. Both innate and adaptive immune responses participate in disease pathogenesis. Studies in animal models and in man have shown that NK cells

Difficult therapeutic decisions in the m
Difficult therapeutic decisions in the management of diabetic retinopathy
โœ Graham P. Leese ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 167 KB ๐Ÿ‘ 2 views

Management decisions for patients with diabetic eye disease can remain difยฎcult despite the presence of guidelines. The cases below illustrate the dilemmas about the timing of instituting insulin in patients needing laser photocoagulation for improvement of glycaemic control. The use of angiotensin-

Hyperactive Ras as a therapeutic target
Hyperactive Ras as a therapeutic target in neurofibromatosis type 1
โœ Weiss, Brian; Bollag, Gideon; Shannon, Kevin ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 38 KB ๐Ÿ‘ 2 views

The NF1 gene encodes neurofibromin, a GTPase-activating protein (GAP) for members of the p21 ras (Ras) family, which negatively regulates Ras output by accelerating the conversion of active RasะธGTP to inactive RasะธGDP. Analysis of tumors from patients with neurofibromatosis type 1 (NF1) has shown bi